Stay updated on Immuno-Therapy in Newly Diagnosed GBM Clinical Trial
Sign up to get notified when there's something new on the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page.

Latest updates to the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page
- Check4 days agoChange DetectedA new revision label, v3.5.4, has been added. The previous label v3.5.3 has been removed.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe ClinicalTrials.gov page footer revision label was updated from v3.5.2 to v3.5.3, indicating a site/version update without changing the displayed study details.SummaryDifference0.0%

- Check33 days agoChange DetectedOno Pharmaceutical Co., Ltd. and Revision: v3.5.2 were added, while Ono Pharmaceutical Co. Ltd and Revision: v3.5.0 were removed.SummaryDifference0.0%

- Check47 days agoChange DetectedUpdated the location entry from Padua, Italy, 35128 to Padova, Italy, 35128 in the study locations.SummaryDifference0.0%

- Check62 days agoChange DetectedVersion updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision: v3.4.3 added and Revision: v3.4.2 removed.SummaryDifference0.0%

Stay in the know with updates to Immuno-Therapy in Newly Diagnosed GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page.